Europe Aesthetic Injectable Market Size & Outlook
Europe aesthetic injectable market, 2018-2030 (US$M)
Related Markets
Europe aesthetic injectable market highlights
- The Europe aesthetic injectable market generated a revenue of USD 2,795.8 million in 2023.
- The market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, botulinum toxin was the largest revenue generating product in 2023.
- Hyaluronic Acid is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,795.8 million |
| Market revenue in 2030 | USD 5,645.6 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin |
| Fastest growing segment | Hyaluronic Acid |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.4% of the global aesthetic injectable market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,437.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aesthetic Injectable Market Scope
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe aesthetic injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.76% in 2023. Horizon Databook has segmented the Europe aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
In Germany, aesthetic injectables fall under the purview of the Federal Institute for Drugs and Medical Devices (BfArM). To gain marketing approval, companies must adhere to strict regulations and undergo a rigorous evaluation process.
Aesthetic injectables, like other medical devices, require CE marking, signifying that they meet EU standards for safety & performance. This classification system categorizes products based on their risk level, with higher-risk products subject to more stringent requirements.
France's regulatory agency responsible for aesthetic injectables is the National Agency for the Safety of Medicines and Health Products (ANSM). ANSM conducts thorough reviews to assess the safety and efficacy of these products. The regulatory framework also includes strict guidelines governing product claims and advertising.
Reasons to subscribe to Europe aesthetic injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe aesthetic injectable market databook
-
Our clientele includes a mix of aesthetic injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe aesthetic injectable market, including forecasts for subscribers. This continent databook contains high-level insights into Europe aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe aesthetic injectable market size, by country, 2018-2030 (US$M)
Europe Aesthetic Injectable Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
